Oral abstract session featuring the latest research on Practical Immonuhematology
Evaluate RBC antigen typing discrepancies between micro-array molecular method and serologic antigen typing confirmation.
Detail an investigational reagent capable of effectively and successfully neutralizing therapeutic anti-CD47 interference in patient pretransfusion testing.
Demonstrate an updated flow cytometry assay for the quantitation of erythrocyte D antigen sites.
Describe the first 25 years of the American Rare Donor Program, including the growth in rare donors in the program, the growth in requests for rare blood products, and the ability of the program to fill requests.
National Institutes of Health, Clinical Center, Department of Transfusion Medicine